This inventor holds 4 USPTO granted patents. Top assignees: Ares Trading S.a., Fresenius Kabi Deutschland Gmbh. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Thomas Solacroup: Innovator in Cell Culture Technologies
Introduction
Thomas Solacroup is a notable inventor based in Blonay, Switzerland. He has made significant contributions to the field of biotechnology, particularly in cell culture methods. With a total of 4 patents to his name, Solacroup's work focuses on enhancing cell viability and biosimilarity in recombinant protein production.
Latest Patents
Among his latest patents, one is titled "Cell culture methods for increased cell viability." This invention relates to a method of maintaining cell viability at a level of at least 80% for up to 14 days in a fed-batch culture of cells producing a recombinant protein. The method involves maintaining the cell culture medium at a pH of 6.5 to 7.0 and at a temperature of 31°C to 35°C for at least 5 consecutive days during the cell culture process. Another significant patent is "Methods for increasing biosimilarity," which describes a method of enhancing the biosimilarity of a TNF α binding protein to a reference TNF α binding protein. This is achieved by modifying the charge profile of the binding protein produced in cell culture by adjusting the concentration of a metal ion in the cell culture medium.
Career Highlights
Throughout his career, Thomas Solacroup has worked with several prominent companies in the biotechnology sector. Notable among these are Ares Trading S.A. and Fresenius Kabi Deutschland GmbH. His experience in these organizations has contributed to his expertise in cell culture technologies and protein production.
Collaborations
Solacroup has collaborated with several professionals in his field, including Matthieu Stettler and Hervé Broly. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in biotechnology.
Conclusion
Thomas Solacroup stands out as an influential inventor in the realm of cell culture technologies. His patents reflect a commitment to advancing the field and improving the efficiency of recombinant protein production. His contributions continue to impact the biotechnology industry positively.